Amarin Corp. Plc
(NASDAQ : AMRN)

( )
AMRN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
CTLTCatalent, Inc. 0.05%85.552.1%$238.77m
SAVACassava Sciences, Inc. 11.20%10.920.0%$190.36m
JAZZJazz Pharmaceuticals Plc 0.00%138.982.4%$167.77m
HZNPHorizon Therapeutics Plc 0.58%79.305.8%$158.76m
CORTCorcept Therapeutics, Inc. -4.91%17.115.5%$125.22m
VRXValeant Pharmaceuticals International, Inc. 0.91%16.6814.1%$98.15m
BHCBausch Health Cos., Inc. 0.91%16.680.0%$66.20m
AMRNAmarin Corp. Plc 0.25%4.021.5%$58.19m
MYOKMyoKardia, Inc. 1.87%128.711.8%$58.13m
ARGXargenx SE -2.86%241.890.0%$53.39m
SAGESAGE Therapeutics, Inc. -0.53%59.568.6%$46.58m
GWPHGW Pharmaceuticals Plc -0.56%99.506.2%$42.69m
AXSMAxsome Therapeutics, Inc. 0.97%79.551.9%$39.23m
MRNSMarinus Pharmaceuticals, Inc. 1.25%3.251.9%$37.99m
PRGOPerrigo Co. Plc -0.41%45.736.8%$35.76m

Company Profile

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.